Clinical trials in diffuse large B cell lymphoma

Trial Name

Description

Click the link for more information (external page)

GEN3013

Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non Hodgkin lymphoma

Suitable for patients with B cell non-Hodgkin lymphoma which has come back after previous treatment

BI 1206 CRUK CD32b

Phase 1/2a study looking at blocking the CD32b protein with the antibody BI 1206.

Suitable for patients with lymphoma which has come back after previous treatment

JCAR017

         Phase 2 study determining efficacy and safety of JCAR017

         Suitable for patients with lymphoma which has come back after previous treatment

LYMRIT 37 05

Phase 1 study of the antibody Betalutin® which targets the CD37 antigen.

Suitable for patients with lymphoma which has come back after previous treatment.

MaPLe

Non-medicinal (observational) study involving molecular profiling on patients with suspected or confirmed DLBCL or grade 3b follicular lymphoma

RiVa

Phase 2 trial testing the combination of rituximab and varlilumab in people with high grade and low grade lymphomas

Suitable for patients with lymphoma which has come back after previous treatment

GO29781

A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab

Suitable for patients with lymphoma which has come back after previous treatment